G. Caramori (Messina (ME), Italy), H. Kankaanranta (Seinäjoki, Finland)
Late Breaking Abstract - Aerosolized gold nanoparticles as a vehicle for prolonged donor lung treatment
A. URSO (New York, United States of America), V. Collico (Milan, Italy), M. Colombo (Milan, Italy), F. Meloni (Pavia, Italy), C. Damoci (New York, United States of America), G. Garcia (San Diego, United States of America), K. Sugahara (New York, United States of America), F. D'Ovidio (New York, United States of America)
|    |
Late Breaking Abstract - CRAC channel inhibition by RP3128 triggers potent anti-inflammatory effects in COPD or asthmatic patient-derived primary cells
S. Viswanadha (La Chaux-de-Fonds, Switzerland), J. Cortijo (Valencia, Spain), J. Milara (Valencia, Spain), S. Vakkalanka (La Chaux-de-Fonds, Switzerland)
| |
Late Breaking Abstract - Increased type 2 inflammation in patients with asthma post rhinovirus infection
T. Southworth (Manchester, United Kingdom), C. Pattwell (Manchester, United Kingdom), S. Mowbray (Cambridge MA, United States of America), R. Strieter (Cambridge MA, United States of America), V. Erpenbeck (Basel, Switzerland), D. Singh (Manchester, United Kingdom)
| |
Late Breaking Abstract - Insulin potentiates methacholine and serotonin-induced increases in tracheal smooth muscle intracellular calcium
B. Proskocil (Portland, United States of America), D. Jacoby (Portland , United States of America), A. Fryer (Portland, United States of America), Z. Nie (Portland, United States of America)
| |
Late Breaking Abstract - Development of an ex vivo pediatric preclinical model of bronchopulmonary dysplasia for aerosol regional deposition studies
Y. Montigaud (Saint-Etienne, France), S. Perinel (Saint-Etienne, France), J. Dubus (Marseille, France), M. Suau (Saint-Etienne, France), L. Leclerc (Saint-Etienne, France), N. Prevot (Saint-Etienne, France), J. Pourchez (Saint-Etienne, France)
| |
Late Breaking Abstract - TGF-ß impairs fibroblast ability to support lung organoid formation: pharmacological restoration by GSK-3 inhibition and secreted niche factor supplementation
J. Ng-Blichfeldt (Groningen, Netherlands), V. Guryev (Groningen, Netherlands), P. Hiemstra (Leiden, Netherlands), T. De Jong (Groningen, Netherlands), R. Kortekaas (Groningen, Netherlands), J. Stolk (Leiden, Netherlands), M. Königshoff (Denver, United States of America), R. Gosens (Groningen, Netherlands)
| |
Late Breaking Abstract - Daily physical activity in patients with severe eosinophilic asthma and the effect of anti-IL5 therapy.
M. Panagiotou (Athens, Greece), A. Koutsoukou (Athens, Greece), N. Koulouris (Athens, Greece), N. Rovina (Athens, Greece)
| |
Late Breaking Abstract - Explore the effective dose of bronchodilator nebulization via high flow nasal cannula in adult COPD and asthma patients
J. Li (Chicago, United States of America), M. Hadeer (Urumqi, China), M. Zhao (Urumqi, China), J. Fink (Chicago, United States of America)
| |